Victor Hugo Callejon Avallone

TozziniFreire Advogados

Articles

Results 1 to 2 of 2


In review: the life sciences regulatory regime in Brazil

Brazil - February 23 2022 This article reviews the essential regulatory considerations surrounding medicines and medical devices in Brazil, including clinical trials and marketing authorisations.

Guilherme Ribas, Marco Aurélio Torronteguy

Spotlight: medicine and medical device pricing and reimbursement in Brazil

Brazil - February 23 2022 An examination of the key legal and practical issues surrounding the pricing and reimbursement of medicinal products and medical devices in Brazil.

Guilherme Ribas, Marco Aurélio Torronteguy